Titan Biotech Ltd.
BSE: 524717 | Sector: Health care |
NSE: N.A. | ISIN Code: INE150C01011 |
BSE 00:00 | 27 May | 229.75 |
3.65 (1.61%) |
OPEN
226.10 |
HIGH
235.00 |
LOW
225.05 |
NSE 05:30 | 01 Jan | Titan Biotech Ltd Not listed in NSE |
OPEN | 226.10 |
PREVIOUS CLOSE | 226.10 |
VOLUME | 7163 |
52-Week high | 423.60 |
52-Week low | 213.00 |
P/E | 9.24 |
Mkt Cap.(Rs cr) | 190 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Titan Biotech Ltd.
Titan Biotech Ltd. the New Delhi based company is into manufacture of Biological Peptones Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc Checking the sensitivity of antibiotics in pharmaceutical industry ch...> More
Titan Biotech Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
190 | |
EPS - TTM | (![]() |
[*S] | 24.87 |
P/E Ratio | (X) | [*S] | 9.24 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | 15.00 | |
Latest Dividend Date | 16 Sep 2021 | ||
Dividend Yield | (%) | 0.65 | |
Book Value / Share | (![]() |
[*S] | 93.22 |
P/B Ratio | (![]() |
[*S] | 2.46 |
Announcement
-
Board Meeting Intimation for Considering Audited Financial Results And Recommendation Of Dividend On
-
Annoucement Under Regulation 30 Regarding Appointment Of Secretarial Auditor Etc
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Titan Biotech Ltd - Financial Results
Particulars (![]() |
Dec 2021 | Dec 2020 | % Chg |
Net Sales | 35.97 | 34.6 | 3.96 |
Other Income | 0.23 | 0.14 | 64.29 |
Total Income | 36.19 | 34.73 | 4.2 |
Total Expenses | 27.27 | 24.83 | 9.83 |
Operating Profit | 8.92 | 9.91 | -9.99 |
Net Profit | 5.94 | 6.82 | -12.9 |
Equity Capital | 8.26 | 8.26 | - |
Titan Biotech Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Smruthi Organic | 182.20 | 1.36 | 208.62 |
Brooks Lab. | 83.60 | 1.95 | 206.49 |
Mangalam Drugs | 120.65 | 8.16 | 190.99 |
Titan Biotech | 229.75 | 1.61 | 189.77 |
SMS Lifesciences | 620.45 | 4.61 | 187.38 |
Kimia Bioscien. | 38.70 | 0.78 | 183.05 |
Lasa Supergeneri | 43.55 | 0.81 | 177.12 |
Titan Biotech Ltd - SHAREHOLDING PATTERN
|
|
Titan Biotech Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -6.62% | NA | 1.03% | 0.53% |
1 Month | -11.62% | NA | -4.31% | -4.93% |
3 Month | -5.00% | NA | -1.74% | -1.84% |
6 Month | -17.39% | NA | -3.89% | -3.96% |
1 Year | -26.36% | NA | 7.37% | 6.62% |
3 Year | 415.13% | NA | 38.31% | 37.13% |
Titan Biotech Ltd - STOCK STRENGTH
Today's Low/High | 225.05 | 235.00 | |
Week Low/High | 222.35 | 251.00 | |
Month Low/High | 213.00 | 276.00 | |
YEAR Low/High | 213.00 | 424.00 | |
All TIME Low/High | 1.05 | 424.00 |
Quick Links for Titan Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices